Different enterococci species are normally found as normal flora in human, mammals, birds, reptiles, and insects ([@CIT0001]). The emergence and rapid spread of antibiotic resistance in enterococcus has become a serious public health concern. Vancomycin is a glycopeptide antibiotic, which is considered as the last lines of defense against many multiresistant Gram-positive cocci. Vancomycin-resistant enterococci (VRE) are one of the organisms responsible for hospital-acquired infections with a high morbidity and mortality in humans ([@CIT0002], [@CIT0003]). Resistance to vancomycin is caused by a series of genes (classified by the prefix *van*) that encode an enzyme important for the cell wall. There have been nine genes described in different species of enterococci: *vanA*, *vanB*, *vanC*, *vanD*, *vanE*, *vanG*, *vanL*, *vanM*, and *vanN* ([@CIT0004]--[@CIT0007]). However, *E. faecium* and *E. faecalis* carrying *vanA* or *vanB* gene have received the most attention in relation to human health care because of their clinical importance, transferability potential, and abundance in clinical isolates ([@CIT0008]--[@CIT0010]).

VRE have been reported in the hospitals of many countries throughout the world and spread is associated with poor hospital hygiene practice ([@CIT0008], [@CIT0011]). Different livestock species in different countries have been reported as potential reservoirs for vancomycin-resistant determinants ([@CIT0012], [@CIT0013]). VRE carrying the *vanA* gene were found in wild birds, including glaucous gulls (*Larus hyperboreus*) and wintering rooks (*Corvus frugilegus*) ([@CIT0014], [@CIT0015]). Different livestock species and/or humans were thought to be sources of VRE in free-living wild bird populations ([@CIT0015]--[@CIT0017]). Previously, we reported the house crow (*Corvus splendens*) and brown-headed gull (*Chroicocephalus brunnicephalus*) living close to human activities and hospital areas as potential carriers of clinically associated extended spectrum beta-lactamases (ESBL)-producing bacteria in Bangladesh ([@CIT0018], [@CIT0019]). There is no information regarding carriage of VRE among these wild birds that were reported to be carriers of ESBL producers.

The aim of this study was to determine the prevalence of VRE in crows foraging in hospital areas of Bangladesh and to investigate whether this bird species constitutes a potential reservoir for VRE.

Materials and methods {#S0002}
=====================

In total, 238 fresh fecal samples from house crows (*C. frugilegus*) were collected during February 2010 from the ground areas of Rajshahi Medical College Hospital (*n*=200) and Chittagong Medical College Hospital of Bangladesh (*n*=38). Fresh fecal droppings were collected by sterile cotton swabs, which after collection were immediately stored at −80°C in bacterial freeze media containing Luria--Bertani broth (Becton, Dickinson and Company, Sparks, MD), phosphate-buffered saline, and 4.4% glycerol. Samples were shipped to Sweden for analysis and cold chain logistics were used for shipment. Fecal samples in bacterial freeze media were inoculated by sterile swabs. The swabs were immediately inoculated with the sample into 1 mL bile azide esculin broth and stored at −70°C for analysis.

Screening for VRE was performed in a selective bile azide esculin broth supplemented with 4 mg/L vancomycin and 60 mg/L aztreonam (ICN Biomedicals, Inc., Aurora, OH), and PCR for *vanA* and *vanB*, according to the methods described previously ([@CIT0020], [@CIT0021]). Briefly, this real-time PCR protocol was used to detect the *vanA* and *vanB* gene. Amplification was conducted in a total volume of 20 µL containing 12.1 µL of PCR water, 4 µL of LC480 M-Mix (2×), 0.4 µL of *vanA* F (10 µM) (5′-CGGCAAGACAATATGACAGCAA-3′), 0.4 µL of *vanA* R (10 µM) (5′-TCAGTACAATGCGGCCGTTA-3′), 0.4 µL of *vanB* F (10 µM) (5′-GGGAGGATGGTGCGATACA-3′), 0.4 µL of *vanB* R (10 µM) (5′-CCGAAATCGCTTGCTCAA-3′), 0.15 µL of *vanA* prob (10 µM) (5′-HEX-CAGTTATAACCGTTCCCGCAGACCTT-BHQ1-3′), 0.15 µL of *vanB* prob (10 µM) (5′-FAM-CTTTGTGAAGCCGGCACGGTCAGGTT-BHQ1-3′), and 2 µL of the samples. The following cycling parameters were used in the PCR run: 95°C for 5 min (95°C for 10 s, 60°C for 30 s) for 45 cycles. Finally, the amplified PCR product was analyzed.

Results, discussion, and conclusion {#S0003}
===================================

All together 238 fecal samples were analyzed. Surprisingly, none of them demonstrated a color change after testing in the bile azide esculin broth meaning no growth of enterococci was demonstrated. Neither *vanA* nor *vanB* were confirmed through PCR screening. These results indicate that there was no VRE carriage by the house crows in Bangladesh. As the testing in bile azide esculin broth did not demonstrate growth of any enterococci, the findings may be interpreted as a low propensity of crows to carry enterococci in general, and thus also to carry VRE. However, previous findings of VRE among birds of the genus *Corvus* ([@CIT0015], [@CIT0017]) indicate that carriage of VRE is indeed possible, and that crows therefore can be used as sentinels. VRE also reported in different wild bird species like European robins (*Erithacus rubecula*), quail (*Coturnix coturnix conturbans*), Common chaffinch (*Fringilla coelebs*), Blackcap (*Sylvia atricapilla*) and buzzards (*Buteo buteo*) ([@CIT0016], [@CIT0022]). More interestingly, wild birds very close to contact with human activities, for example crows and gulls, are potential carriers of clinically important VRE ([@CIT0014], [@CIT0017]). A study from Bangladeshi hospitals showed a low prevalence (3%) of *E. faecalis* among patients with urinary tract infections ([@CIT0023]). Another study from Bangladesh showed that *E. faecalis* is the dominant species among patients with Enterococcus infection and all *E. faecalis* and *E. facium* strains isolated from patients were resistant to vancomycin ([@CIT0024]). Thus, VRE is a serious challenge for hospitals; however, there are no reports about the prevalence of VRE from livestock, poultry, or wild birds in Bangladesh.

The house crow (*C. splendens*) has a widespread distribution in South Asian countries like Bangladesh and India, and it lives close to humans. It occupies different ecological niches, including household areas, city dumps, hospital dumps, and water sources like lakes, ponds, and rivers. The house crow has been shown to carry several human pathogenic bacteria in its intestines ([@CIT0025], [@CIT0026]). A study on these samples demonstrated that 59% of the crows living on hospital waste were potential carriers of clinically relevant ESBL-producing *E. coli* and *Klebsiella* ([@CIT0019]), and hospital waste has been reported as a potential source of antibiotic-resistant bacteria ([@CIT0019], [@CIT0027]). These crows were reported as potential carriers of clinical relevant human-associated ESBL-producing *E. coli* ST13-O25b clones, likely because of their foraging behaviors in hospital waste dumps ([@CIT0028]). It has also been documented that wild birds can carry VRE and ESBL-producing bacteria simultaneously ([@CIT0016]). Thus, the high prevalence of ESBL-producing bacteria among crows living in hospital areas has increased our suspicion about the possible carriage and spread of VRE as well, like in Azores, Portugal ([@CIT0016]).

This study indicates the absence of VRE harboring *vanA* and *vanB* genes among crows foraging on hospital wastes even though they were potential carriers of ESBL-producing Enterobacteriaceae ([@CIT0028]). Thus, spread through hospital waste via house crows does not seem to be a major mechanism for dissemination of VRE in Bangladesh. However, proper steps should be taken to stop the possible future environmental spread of VRE, as well as other resistant microorganisms, through hospital waste and from hospitals settings in Bangladesh.
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